adipose depots and development of hypertension. Intraabdominal fat deposition is greater in younger individuals, but continues to accumulate with aging, thereby resulting in the potential for prolonged exposure to its adverse health effects. 12, 13 Therefore, we examined the relationship between change in CT-measured abdominal and thigh fat areas over a 5-year period and the incidence of hypertension over 10 years in a Japanese American cohort of men and women, with the hypothesis that an increase in intra-abdominal fat accumulation will be positively and more strongly associated with development of hypertension than other measured fat depots.
Methods Subjects
The cohort used in this prospective analysis comes from the Japanese American Community Diabetes Study, which enrolled second-and third-generation Japanese Americans of 100% Japanese ancestry from 1983 to 1988 residing in King County, WA. Details on study group characteristics and recruitment methods have been previously described. [14] [15] [16] Participants had follow-up visits at 5 to 6 years and 10 to 11 years after the baseline study visit. The University of Washington Human Subjects Division approved the study, and all subjects provided written informed consent before participation.
For our current analysis, subjects were excluded from the original cohort of 658 individuals if they had a diagnosis of hypertension at baseline, defined by systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or the use of antihypertensive medications. Subjects on oral glucose-lowering medications or insulin at baseline were also excluded. As outlined in the Figure, a total of 286 subjects from 381 were eligible by these criteria and included in the analysis.
History, Anthropometric Measurements, and Glucose Tolerance
Body weight was measured in kilograms and used to calculate body mass index (BMI) as weight in kilograms divided by the square of measured height in meters. Abdominal circumference was measured at the level of the umbilicus in centimeters. After a rest period of ≈30 minutes, blood pressure was measured with a mercury sphygmomanometer in the recumbent position to the nearest 2 mm Hg and reported as an average recording from the second and third of 3 consecutive measurements. Daily dietary sodium intake in milligrams was assessed from a food frequency questionnaire at baseline as described previously. 17 Alcohol consumption was obtained via questionnaires and measured in grams per week. Smoking status was defined at the baseline visit as current, former, or never smoker. Weekly energy expenditure, in kcal per week, was estimated by responses from questionnaires on self-reported activities, including data on sports, strenuous activities, distance walked, and stairs climbed.
15,18 Self-reported physical activity level at baseline was obtained and ranked on a categorical scale from sedentary to heavy.
After an overnight 10-hour fast, plasma glucose levels from a 75-g oral glucose tolerance test were used to define diabetes mellitus and pre-diabetes mellitus using American Diabetes Association criteria. 19 Fasting insulin levels were measured by radioimmunoassay and used as a surrogate marker of insulin sensitivity. 20, 21 CT was used to obtain single slice imaging of the abdomen at the level of the umbilicus to measure the cross-sectional abdominal subcutaneous and intra-abdominal fat areas. Thigh subcutaneous fat area was measured midway between the greater trochanter and superior margin of the patella. All areas were calculated in square centimeter, by guest on May 30, 2017 http://hyper.ahajournals.org/ Downloaded from as detailed previously. 22 Intra-abdominal fat area was used to estimate visceral adiposity because this fat depot has been shown to have a high correlation with visceral adipose tissue volume estimates with CT or MRI. 23, 24 Subjects underwent repeat testing of all measurements, including laboratory and CT-measurements at 5-to 6-and 10-to 11-year follow-up examinations.
Calculations and Statistical Analysis
Change in CT-measured fat area was calculated as the difference between the 5-year and baseline measurements. Subjects were defined as developing hypertension if they met diagnostic criteria (systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or the use of antihypertensive medications) at either the 5-to 6-year or 10-to 11-year visit.
Multiple logistic regression analysis was used to calculate the adjusted odds ratio (OR) of incident hypertension at 10-year follow-up in relation to a 5-year increase in specific CT-measured fat depots. The presence of multicollinearity in multivariable models was evaluated using the variance inflation factor, with a value >4 suggesting its presence. 25 Both BMI and baseline fat depot were included in models looking at change in fat depots as evidence for correlation between these variables was low (Table S1 in the online-only Data Supplement). OR and the 95% confidence interval (CI) for continuous variables are listed for a 1-SD increment. Quartiles of baseline intra-abdominal fat area were used in logistic models because previous analyses in this cohort have demonstrated that this fat depot has a nonlinear association with hypertension. 5, 6 The better fit of the models predicting hypertension that included quartiles of baseline intra-abdominal fat area when compared with the continuous form of this variable was confirmed in our analysis by the Akaike Information Criteria. 26 The continuous measurement of change in intra-abdominal fat area was used for our analysis because this resulted in a better fit in a bivariate model predicting hypertension incidence as judged by Akaike Information Criteria. Interaction by sex and age with change in fat areas in relation to incident hypertension was tested by insertion of first-order interaction terms between these variables into regression models. P-values were 2-tailed and determined to be statistically significant if P<0.05. Statistical analysis was performed using STATA, version 12.1 (Stata Corp, College Station, TX)
Results

Baseline Characteristics
A total of 286 subjects were followed up from baseline to a 10-or 11-year follow-up. Baseline characteristics of the cohort were 50.4% men, mean age of 49.5±11.6 years, BMI 23.7±3.1 kg/m 2 , and intra-abdominal fat area of 70.3±43.6 cm 2 (±SD). Even with the exclusion of subjects on glucoselowering medications, there were 105 subjects with a classification of pre-diabetes mellitus and 21 with diabetes mellitus. Eighty-two cases of hypertension developed over the followup period. Baseline characteristics of the subjects by incident hypertension are shown in Table 1 . Table 2 lists the unadjusted OR for incident hypertension at follow-up. Baseline and 5-year change in intra-abdominal fat area had a significant association with the odds of incident hypertension. Baseline abdominal subcutaneous fat area was significantly associated with hypertension; however, change in this fat depot was not. Neither baseline thigh subcutaneous fat area nor a change in this region was significantly related with the development of hypertension. Unadjusted age, systolic and diastolic blood pressures, fasting and 2-hour plasma glucose levels, pre-diabetes mellitus status, and BMI all were significantly associated with incident hypertension.
Unadjusted Predictors of Development of Hypertension
Adjusted Predictors of Development of Hypertension
We next examined multivariable models to determine the adjusted OR for incident hypertension by baseline and change in specific adipose depots. All models were adjusted for age, sex, BMI, alcohol intake, weekly energy expenditure, and smoking status. The adjusted third and fourth quartiles of baseline intra-abdominal fat area were significantly associated with a 10-year incidence of hypertension (OR, 2.85; 95% CI, 1.00-8.10 for quartile 3 versus 1 and OR, 3.37; 95% CI, 1.04-10.86 for quartile 4 versus 1). Baseline thigh and abdominal subcutaneous fat areas were not associated with incident hypertension (data not shown.) Table 3 lists the adjusted OR for a 5-year change in fat depots. Change in intra-abdominal fat area was significantly associated with incident hypertension. If additionally adjusted for baseline systolic or diastolic blood pressure, change in intra-abdominal fat area remained associated with incident hypertension (OR, 1.89; 95% CI, 1.36-2.62 and OR, 1.73; 95% CI, 1.27-2.36, respectively). Change in intra-abdominal fat area remained associated with incident hypertension when further adjusted for change in either thigh or abdominal subcutaneous fat area. Change in neither thigh nor abdominal subcutaneous fat area was significantly related to the development of hypertension, even when adjusted for baseline or change in the intra-abdominal fat area. Adjusting these models for self-reported physical activity in place of weekly energy expenditure did not change these associations (data not shown).
These models were further adjusted for baseline fasting insulin and 2-hour plasma glucose and baseline diabetes mellitus and pre-diabetes mellitus classification (Table S2) . Change in intra-abdominal fat area remained significantly associated with incident hypertension, whereas the change in thigh or abdominal subcutaneous fat area was not associated with the outcome. The associations between change in fat areas and incident hypertension did not vary by sex or by age as first-order interaction terms between sex or age and change in the intra-abdominal, abdominal subcutaneous, and thigh fat depots were all nonsignificant when inserted in Table 3 models (P>0.05). Although there was no significant interaction in the association between hypertension and change in fat depot area by sex, we present sex-stratified results in Tables S3 to  S8 . The combined analyses in men and women, however, constitute the main results.
We additionally examined the 5-year change in BMI and abdominal circumference and incident hypertension. A 5-year change in BMI, adjusted for sex, age, baseline BMI, alcohol intake, weekly energy expenditure, and smoking status as baseline was significantly associated with incident hypertension. However, when further adjusted for change in intra-abdominal fat area, this relationship was no longer significant. A 5-year change in abdominal circumference was not significantly associated with incident hypertension (results not shown).
A subset analysis was performed by excluding subjects who developed hypertension by the 5-or 6-year follow-up to examine subjects who developed hypertension after the measured change in fat depots. Fifty-two subjects were removed from this analysis, resulting in a subcohort of 234 subjects with a 12.8% incidence of hypertension. In this model, a 5-year change in intra-abdominal fat (adjusted for age, sex, BMI, baseline intra-abdominal fat, alcohol intake, weekly energy expenditure, and smoking status) remained significantly associated with incident hypertension (data not shown).
Discussion
In this prospective cohort study, we have demonstrated that in Japanese Americans, the risk of developing hypertension is related to the accrual of intra-abdominal adipose tissue. This observation was independent of age, sex, BMI, alcohol intake, weekly energy expenditure, smoking status, diabetes mellitus or pre-diabetes mellitus classification, and surrogate markers of insulin sensitivity. Change in neither abdominal subcutaneous fat nor thigh subcutaneous fat was related to incident hypertension.
Previous research has demonstrated that fat depot locations differ in their associations with cardiometabolic disease. Previous work from the Japanese American Community Diabetes Study demonstrated that baseline intra-abdominal fat area is associated with the prevalence and incidence of hypertension in participants not on blood pressure or glucose-lowering medications. 5, 6 The current analysis is unique in that it demonstrates that change in CT-measured intra-abdominal fat is associated with incident hypertension, independent of other adipose depot areas and generalized adiposity as measured by BMI. A subset analysis was performed to determine whether change in intra-abdominal fat precedes development of hypertension. After excluding subjects who developed hypertension at the 5-year follow-up, change in intra-abdominal fat remained associated with incident hypertension, suggesting that change in this depot may precede the development of hypertension and play a role in its pathogenesis. A related longitudinal study in Canada examined change in cardiorespiratory fitness, including blood pressure, by 6-year change in visceral fat among healthy men and women. 27 Change in visceral fat was significantly associated with variance explained for change in both systolic and diastolic blood pressure, but it is not clear whether participants developed hypertension. In addition, a cross-sectional study in French Canadian young adults found that MRI-measured visceral adipose tissue had a positive and stronger association with markers of cardiovascular health, including systolic and diastolic blood pressures, than other adipose depots. 28 Although previous studies have suggested that certain adipose depots may be protective against the metabolic syndrome and cardiovascular disease, we did not find a protective effect of greater lower body or abdominal subcutaneous adipose tissue on incident hypertension, even after adjusting for intra-abdominal fat area. This difference may be because most data have been reported from cross-sectional analyses. In addition, some studies suggesting lower body adiposity has favorable effects on cardiovascular disease did not control for the intra-abdominal adipose depot, which may have influenced results. 10 Previous cross-sectional data from the AusDiab study that demonstrated greater hip circumference was associated with lower prevalence of hypertension in men cannot be directly compared with our data because this circumferential measurement does not distinguish between adipose versus muscle at this location. 29 Some data suggesting that lower body adiposity is cardioprotective have focused on other components of the metabolic syndrome, such as insulin sensitivity, high-density lipoprotein levels, or triglycerides, or did not examine hypertension independent of the metabolic syndrome, and therefore it may not be possible to infer a similar effect on risk of hypertension. [30] [31] [32] [33] We additionally examined the relationship between change in BMI, a marker of total adiposity, and incident hypertension. An unadjusted change in BMI seemed to have a significant association with incident hypertension; however, when this measurement was further adjusted for change in intra-abdominal fat area, the association was lost. Change in abdominal circumference additionally did not seem to be associated with development of hypertension. These findings are not surprising because BMI is not considered to be a useful measure of specific fat depots, and abdominal circumference measurements cannot distinguish between visceral and subcutaneous adiposity. 4 These findings suggest that simple anthropometric measurements have limitations when investigating the relationship between regional fat depots and risk of hypertension and perhaps other cardiovascular risks.
There are potential limitations to this study. First, our results are from a Japanese American cohort and it is unknown whether the findings can be applied to other ethnic groups. However, recent data from the Dallas Heart Study, comprised of black, white, and Hispanic individuals, demonstrated greater visceral adipose tissue and, in particular, retroperitoneal fat, was 34 Second, we used a single CT slice to estimate adipose depot size. Previous work with this cohort has demonstrated that intra-abdominal fat measurement from a single slice is highly correlated with visceral fat volume as assessed from a multiple-slice CT scanning protocol (r=0.89-0.94). 23, 24 For our analysis, intra-abdominal fat was measured at the L4-L5 level, and CT-measurement at this site has been shown to be an accurate estimate of total visceral fat. 23 In using a single slice for adipose measurement, there is also a potential limitation when comparing longitudinal CT fat areas of measurement error because of positioning of subjects and acquisition of images. Third is a potential for confounding bias in our results. We addressed this problem by adjusting our models for age, sex, BMI, 2-hour glucose level, fasting insulin, diabetes mellitus and pre-diabetes mellitus classification, alcohol intake, weekly energy expenditure, and smoking status at baseline. As is true for any observational study, the presence of potentially unknown or unmeasured confounding variables cannot be excluded. Fourth, there may have been a selection bias from excluding participants who were lost to follow-up or had missing data. Seventy-five percent of subjects who qualified for entry into the study completed follow-up. The potential exists for bias if this excluded group had a different risk of hypertension in relation to visceral fat deposition than those who were included in the analysis. However, baseline characteristics did not differ between those included in and those excluded from the study, except for mean fasting insulin (data not shown), suggesting this is unlikely, because there was no significant association between fasting insulin concentration and incident hypertension.
On the basis of observational study design used for this analysis, one cannot assume a causal mechanism between the higher odds of hypertension development in association with intra-abdominal fat increase. There are multiple theories on how adipose and specific fat depots contribute to the development of hypertension. One notion is the insulin resistance and hyperinsulinemia seen with abdominal obesity contributes to the pathogenesis of hypertension via endothelial dysfunction, sodium retention, increased sympathetic activity and vascular hypertrophy. [1] [2] [3] In our study, change in the intra-abdominal adipose depot remained associated with hypertension after adjusting for fasting plasma insulin (a surrogate marker of insulin sensitivity) and 2-hour glucose levels, as well as for diabetes mellitus and pre-diabetes mellitus classification. These findings suggest that the influence of this adipose depot may be independent of effects of insulin resistance or dysglycemia on hypertension. Other proposed mechanisms include increased angiotensinogen gene expression in this fat depot, an inverse relationship with beneficial fat hormones, such as adiponectin, and increased free fatty acid production. [35] [36] [37] In addition, it is thought that intra-abdominal adipose tissue compared with subcutaneous adipose tissue is unable to continuously accommodate to increased deposition in this region. 37, 38 This may be, in part, because of the loss of the ability of adipocytes to differentiate into effective lipid storage cells and an imbalance between free fatty acid and leptin production; thus, fat accumulation in this depot is expected to have deleterious effects on the cardiovascular system. 37, 39 In conclusion, we have demonstrated in Japanese Americans that change in the intra-abdominal adipose tissue depot is the critical region related to the development of hypertension. None of the other fat depots studied were associated with the development of hypertension. Furthermore, it seems that accumulation of intra-abdominal fat precedes the increase in blood pressure, and therefore may play a role in the development of hypertension and cardiovascular disease in Japanese Americans. Additional study will be required to determine whether causality explains this association, which may provide targets for adipose-directed interventions for the prevention or treatment of hypertension.
Perspectives
In this Japanese American population, change in the intraabdominal fat depot is associated with development of hypertension, independent of other measured adipose depots. None of the other fat areas studied or anthropometric measurements of adiposity were associated with incident hypertension. Furthermore, it seems that the accumulation of intra-abdominal fat precedes the increase in blood pressure and therefore may play a role in the development of hypertension. Additional work needs to be done to investigate this relationship and potential therapeutic interventions to better prevent or treat hypertension.
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What Is New?
• Change in intra-abdominal fat is related to the development of hypertension among Japanese Americans.
What Is Relevant?
• Fat deposition and its location have an important role in cardiovascular disease and hypertension, and certain fat depots play a more significant role in development of cardiovascular disease than others.
Summary
This study demonstrates that a recent change in the intra-abdominal fat depot is related to the development of hypertension. None of the other fat depots studied were associated with the development of hypertension. These results suggest a potential causal relationship between the accumulation of intra-abdominal fat and hypertension risk.
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